BioXcel Therapeutics shares surged over 19% after hours ahead of key Phase 3 trial results for its at-home agitation treatment, sparking strong investor interest.
BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know
Where Today's News Shapes Tomorrow
